Dianthus Therapeutics, Inc. financial statements, including revenue, expenses, profit, and loss

The total revenue of DNTH for the last quarter is 1.86 M USD, and it's 113.16% higher compared to the previous quarter. The net income of Q2 24 is -17.61 M USD.